IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 121 filers reported holding IRADIMED CORP in Q4 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $41,172 | -42.3% | 937 | -42.2% | 0.00% | -50.0% |
Q1 2024 | $71,352 | +221.2% | 1,622 | +246.6% | 0.00% | – |
Q4 2023 | $22,216 | +69.7% | 468 | +58.6% | 0.00% | – |
Q3 2023 | $13,089 | +19.2% | 295 | +28.3% | 0.00% | – |
Q2 2023 | $10,980 | +84361.5% | 230 | -28.8% | 0.00% | – |
Q1 2023 | $13 | +44.4% | 323 | +5.6% | 0.00% | – |
Q4 2022 | $9 | -100.0% | 306 | -72.9% | 0.00% | -100.0% |
Q3 2022 | $34,000 | +36.0% | 1,131 | +51.4% | 0.00% | 0.0% |
Q2 2022 | $25,000 | -59.0% | 747 | -45.2% | 0.00% | 0.0% |
Q1 2022 | $61,000 | +7.0% | 1,362 | +10.0% | 0.00% | 0.0% |
Q4 2021 | $57,000 | -44.1% | 1,238 | -59.3% | 0.00% | -66.7% |
Q3 2021 | $102,000 | +580.0% | 3,045 | +499.4% | 0.00% | – |
Q2 2021 | $15,000 | +25.0% | 508 | +9.2% | 0.00% | – |
Q1 2021 | $12,000 | -80.3% | 465 | -82.4% | 0.00% | -100.0% |
Q4 2020 | $61,000 | -54.1% | 2,635 | -57.7% | 0.00% | +100.0% |
Q3 2020 | $133,000 | +454.2% | 6,236 | +492.2% | 0.00% | 0.0% |
Q2 2020 | $24,000 | +700.0% | 1,053 | +784.9% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 119 | -4.8% | 0.00% | – |
Q4 2019 | $3,000 | -92.9% | 125 | -93.8% | 0.00% | -100.0% |
Q3 2019 | $42,000 | +121.1% | 2,024 | +109.3% | 0.00% | +200.0% |
Q2 2019 | $19,000 | +1800.0% | 967 | +3123.3% | 0.00% | – |
Q3 2018 | $1,000 | -98.1% | 30 | -98.8% | 0.00% | -100.0% |
Q2 2018 | $52,000 | +205.9% | 2,487 | +131.8% | 0.00% | +50.0% |
Q4 2017 | $17,000 | +41.7% | 1,073 | -12.9% | 0.00% | +100.0% |
Q3 2017 | $12,000 | – | 1,232 | – | 0.00% | – |
Q2 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2016 | $19,000 | -17.4% | 1,737 | +28.8% | 0.00% | 0.0% |
Q3 2016 | $23,000 | +91.7% | 1,349 | +148.4% | 0.00% | +100.0% |
Q2 2016 | $12,000 | +50.0% | 543 | +36.1% | 0.00% | 0.0% |
Q1 2016 | $8,000 | – | 399 | +7880.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 5 | -99.7% | 0.00% | -100.0% |
Q3 2015 | $47,000 | +6.8% | 1,905 | +1.5% | 0.01% | +25.0% |
Q2 2015 | $44,000 | +2100.0% | 1,876 | +1437.7% | 0.00% | – |
Q1 2015 | $2,000 | -92.9% | 122 | -94.3% | 0.00% | -100.0% |
Q4 2014 | $28,000 | +16.7% | 2,155 | -37.1% | 0.00% | 0.0% |
Q3 2014 | $24,000 | – | 3,425 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 234,810 | $5,013,000 | 5.83% |
Nine Ten Capital Management LLC | 277,088 | $5,916,000 | 2.51% |
RK Capital | 211,325 | $4,512,000 | 2.03% |
Parkman Healthcare Partners LLC | 113,855 | $2,431,000 | 1.13% |
Ranger Investment Management | 235,312 | $5,024,000 | 0.44% |
CADENCE CAPITAL MANAGEMENT LLC | 101,720 | $2,172,000 | 0.37% |
ALGERT GLOBAL LLC | 30,152 | $644,000 | 0.27% |
Mondrian Investment Partners LTD | 163,939 | $3,500,000 | 0.12% |
NAVELLIER & ASSOCIATES INC | 20,800 | $444,000 | 0.10% |
GLOBEFLEX CAPITAL L P | 15,510 | $331,000 | 0.10% |